Search

Your search keyword '"Jeannine Garnett"' showing total 23 results

Search Constraints

Start Over You searched for: Author "Jeannine Garnett" Remove constraint Author: "Jeannine Garnett"
23 results on '"Jeannine Garnett"'

Search Results

1. Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm

2. Regulation of HGF Expression by ΔEGFR-Mediated c-Met Activation in Glioblastoma Cells

3. Cryopreserved human umbilical cord as a meningeal patch during in utero spina bifida repair in a modified ovine model

4. The significance of hindbrain herniation reversal following prenatal repair of neural tube defects

5. Supplementary Data from SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

8. Suture techniques and patch materials using an in-vitro model for watertight closure of in-utero spina bifida repair

9. Cryopreserved human umbilical cord versus acellular dermal matrix patches for in utero fetal spina bifida repair in a pregnant rat model

14. Pentraxin‐3 plasma levels correlate with tumour burden and overall survival in patients with primary myelofibrosis

15. Improved prediction of PARP inhibitor response and identification of synergizing agents through use of a novel gene expression signature generation algorithm

16. Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer

17. Abstract NG14: Proteome instability is an immunogenic therapeutic vulnerability in mismatch repair deficient cancer

18. Increased H3K9me3 drives dedifferentiated phenotype via KLF6 repression in liposarcoma

19. EZH2-miR-30d-KPNB1 pathway regulates malignant peripheral nerve sheath tumour cell survival and tumourigenesis

20. SAR405838: A Novel and Potent Inhibitor of the MDM2:p53 Axis for the Treatment of Dedifferentiated Liposarcoma

21. The hepatocyte growth factor receptor as a potential therapeutic target for dedifferentiated liposarcoma

22. Identification of Kruppel-Like Factor 6 (KLF6) as a Differentially Expressed Transcription Factor and Tumor Suppressor in Well Differentiated and Dedifferentiated Liposarcoma (WDLPS, DDLPS) through Unbiased Epigenetic Approaches

23. AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas

Catalog

Books, media, physical & digital resources